Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020

Roche has hosted a live audio webcast and conference call on Thursday, 6 February 2020.

Live webinar replay

Check out the replay here

Investors

Past IR Events

View more Events

Downloads

Presentation

PDF

Related links

GovernanceAbout Roche

Our corporate governance principles focus on sustainable value creation and prescribe a culture that recognises standards of good corporate governance and policy of transparent communication.

Roche’s Annual Report 2019Investors

How medicines are making an impact in the lives of patients

Product Development PortfolioSolutions

Discover our pipeline of Pharmaceutical and Diagnostics developments

Frequently Asked QuestionsInvestors

We answer the Roche investors-related most frequently asked questions